HUP0401613A3 - A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea - Google Patents

A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea

Info

Publication number
HUP0401613A3
HUP0401613A3 HU0401613A HUP0401613A HUP0401613A3 HU P0401613 A3 HUP0401613 A3 HU P0401613A3 HU 0401613 A HU0401613 A HU 0401613A HU P0401613 A HUP0401613 A HU P0401613A HU P0401613 A3 HUP0401613 A3 HU P0401613A3
Authority
HU
Hungary
Prior art keywords
ethoxy
phenyl
propanoic acid
sulonylurea
tert
Prior art date
Application number
HU0401613A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0401613A2 publication Critical patent/HUP0401613A2/hu
Publication of HUP0401613A3 publication Critical patent/HUP0401613A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0401613A 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea HUP0401613A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101982A SE0101982D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001036 WO2002100413A1 (en) 2001-06-01 2002-05-30 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA

Publications (2)

Publication Number Publication Date
HUP0401613A2 HUP0401613A2 (hu) 2004-11-29
HUP0401613A3 true HUP0401613A3 (en) 2007-11-28

Family

ID=20284364

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401613A HUP0401613A3 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea

Country Status (21)

Country Link
US (1) US20040157927A1 (hu)
EP (1) EP1399166A1 (hu)
JP (1) JP2004532891A (hu)
KR (1) KR20040007624A (hu)
CN (1) CN1250226C (hu)
BR (1) BR0210127A (hu)
CA (1) CA2448763A1 (hu)
CO (1) CO5540382A2 (hu)
CZ (1) CZ20033235A3 (hu)
EE (1) EE200300583A (hu)
HU (1) HUP0401613A3 (hu)
IL (1) IL159035A0 (hu)
IS (1) IS7057A (hu)
MX (1) MXPA03011010A (hu)
NO (1) NO20035235D0 (hu)
PL (1) PL367890A1 (hu)
RU (1) RU2003136157A (hu)
SE (1) SE0101982D0 (hu)
SK (1) SK14722003A3 (hu)
WO (1) WO2002100413A1 (hu)
ZA (1) ZA200309263B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ppar調節剤およびそのスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
CO5540382A2 (es) 2005-07-29
MXPA03011010A (es) 2004-02-27
CA2448763A1 (en) 2002-12-19
IL159035A0 (en) 2004-05-12
IS7057A (is) 2003-11-28
CZ20033235A3 (cs) 2004-12-15
ZA200309263B (en) 2005-03-11
EP1399166A1 (en) 2004-03-24
KR20040007624A (ko) 2004-01-24
BR0210127A (pt) 2004-06-08
WO2002100413A1 (en) 2002-12-19
EE200300583A (et) 2004-02-16
NO20035235D0 (no) 2003-11-25
CN1537008A (zh) 2004-10-13
JP2004532891A (ja) 2004-10-28
RU2003136157A (ru) 2005-05-20
SK14722003A3 (sk) 2004-08-03
CN1250226C (zh) 2006-04-12
HUP0401613A2 (hu) 2004-11-29
PL367890A1 (en) 2005-03-07
US20040157927A1 (en) 2004-08-12
SE0101982D0 (sv) 2001-06-01

Similar Documents

Publication Publication Date Title
DK1237855T3 (da) Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
DE69841531D1 (de) Kennzeichnung von programminformation eines aufzeichnungsmediums
HUP0401613A3 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea
IL159034A0 (en) A pharmaceutical combination comprising either (s) -2-ethoxy-3-[4- (2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}- (s) -2- ethoxy propanoic acid and insulin
PL377735A1 (pl) Pochodne kwasu 4-(3-(2-fenylooksazol-4-ilometoksy)- cykloheksyloksy)- propano-1-karboksylowego i związki pokrewne, jako modulatory PPAR do leczenia cukrzycy typu 2 i stwardnienia naczyń
HUP0400946A3 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug
DE10084485T1 (de) Selbstabstimmender Modellreferenz-Controller in einem Plattenlaufwerk
FR2838218B1 (fr) Affichage des imagettes d'un support photographique sur un terminal
DE60005693D1 (de) Eine kristalline form von 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophen-hydrochlorid
FR2811084B1 (fr) Methode d'identification d'une caracteristique biologique fonctionnelle d'une matiere vivante
NO20000665L (no) 2-{3-[4-(2-t-Butyl-6-trifluormetyl-4-pyrimidinyl)-1- piperazinyl]propyltio}-4-pyrimidinol-fumarat
DE60203142D1 (de) Verfahren zur Herstellung von 4-[1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-butyl]-alpha, alpha-dimethylphenylessigsäure
DE60001751D1 (de) Behälter zur Aufnahme eines Stapels ineinandergefalteter feuchter Tücher
AU2003244922A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
FR2833171B1 (fr) Produit cosmetique/dermatologique a base d'emulsion triple
FR2833656B3 (fr) Compresseur d'air a structure stable
JP3024219U (ja) コンパクトディスク用収納ケース
BR9509087A (pt) Processo para a síntese quantativa do ácido 3-(l-piroglutamil)-l-tiazolidina-4-carboxílico e derivados do mesmo
DE29803343U1 (de) Aufnahme von Kartonagen (Faltschachteln) unterschiedlicher Größe in einem Drehteller
FI980508A0 (fi) 2-(3,5-difluorfenyl)-3-(4-(metylsulfonyl)fenyl)-2-cyklopenten-1-on anvaendbar som COX-2 inhibitor
FI962513A0 (fi) N-(((2-(((2-((diaminometyleeni)amino)-4-tiatsolyyli)metyyli)tio)etyyli)-amino)metyleeni)-4-bromibentseenisulfonamidin A- ja B-muodot
ITMI20011499A0 (it) Procedimento per la realizzazione di parti di calzature e calzature contenenti tali parti cosi' ottenute
IT1307855B1 (it) Processo per la produzione di carta "tissue" e carta cosi' ottenuta.
TH55077EX (th) รองเท้า
ITPT20000006U1 (it) Processo di ottimizzazione dell'evaporazione dell'umidita' contenutanei tubi di carta appena formati

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees